OPTN OptiNose Inc
Price (delayed)
$9.18
Market cap
$92.46M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.12
Enterprise value
$134.46M
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S.
Highlights
OPTN's EPS has soared by 55% YoY and by 45% from the previous quarter
The equity has surged by 53% year-on-year
Key stats
What are the main financial stats of OPTN
Market
Valuations
Earnings
Shares outstanding
10.07M
Market cap
$92.46M
Enterprise value
$134.46M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.72
Revenue
$78.23M
Gross profit
$71M
Operating income
-$16.32M
Net income
-$21.54M
EBIT
-$1.48M
EBITDA
-$1.2M
Free cash flow
-$44.75M
Per share
Balance sheet
Liquidity
EPS
-$2.12
EPS diluted
-$2.12
Free cash flow per share
-$4.41
Book value per share
-$4.01
Revenue per share
$7.7
TBVPS
$12.68
Total assets
$128.79M
Total liabilities
$169.15M
Debt
$126.48M
Equity
-$40.36M
Working capital
-$36.97M
Debt to equity
-3.13
Current ratio
0.77
Quick ratio
0.68
Net debt/EBITDA
-35.06
Margins
Efficiency
Dividend
EBITDA margin
-1.5%
Gross margin
90.8%
Net margin
-27.5%
Operating margin
-20.9%
Return on assets
-18.1%
Return on equity
N/A
Return on invested capital
-2.1%
Return on capital employed
N/A
Return on sales
-1.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OPTN stock price
How has the OptiNose stock price performed over time
Intraday
0.11%
1 week
0.22%
1 month
0.33%
1 year
-36.73%
YTD
37.43%
QTD
0.11%
Financial performance
How have OptiNose's revenue and profit performed over time
Revenue
$78.23M
Gross profit
$71M
Operating income
-$16.32M
Net income
-$21.54M
Gross margin
90.8%
Net margin
-27.5%
OPTN's net margin is up by 45% YoY and by 33% QoQ
OptiNose's net income has increased by 39% YoY and by 31% from the previous quarter
The operating margin has grown by 35% year-on-year and by 18% since the previous quarter
The operating income has increased by 28% year-on-year and by 15% since the previous quarter
Growth
What is OptiNose's growth rate over time
Valuation
What is OptiNose stock price valuation
P/E
N/A
P/B
N/A
P/S
1.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.72
OPTN's EPS has soared by 55% YoY and by 45% from the previous quarter
The equity has surged by 53% year-on-year
OPTN's price to sales (P/S) is 59% less than its 5-year quarterly average of 2.9 and 30% less than its last 4 quarters average of 1.7
OptiNose's revenue has increased by 10% YoY and by 3.4% QoQ
Efficiency
How efficient is OptiNose business performance
OPTN's ROS has soared by 92% YoY and by 87% from the previous quarter
The company's return on invested capital has surged by 87% QoQ
The ROA has grown by 45% YoY and by 34% from the previous quarter
Dividends
What is OPTN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OPTN.
Financial health
How did OptiNose financials performed over time
OptiNose's total assets is 24% less than its total liabilities
OPTN's current ratio is up by 28% year-on-year but it is down by 2.5% since the previous quarter
The quick ratio is up by 28% year-on-year
OptiNose's debt to equity has shrunk by 109% YoY
The equity has surged by 53% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.